Literature DB >> 15857191

Acute syphilitic blindness in an HIV-positive patient.

Mark Oette1, Jan Hemker, Torsten Feldt, Abdurrahman Sagir, Jochen Best, Dieter Häussinger.   

Abstract

This case report describes a rare manifestation of syphilis. An HIV-positive patient with severe immunosuppression presented with rapid loss of vision due to eye involvement of Treponema pallidum infection. The ophthalmologic examination on admittance showed a chorioretinitis, an uveitis, and a swollen optical disc of both eyes. Reconstitution of vision after application of intravenous penicillin occurred within 3 weeks. Despite low HIV prevalence in central Europe, behaviors that promote transmission of HIV and other sexually transmitted diseases tend to increase. The clinical presentation of syphilis may be atypical and the rate of complications is often higher in HIV-infected patients. Thus, Treponema pallidum infection should be considered in immunosuppressed HIV-positive patients presenting with chorioretinitis. Patients should receive treatment similar to that for neurosyphilis if there is suspicion of involvement of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857191     DOI: 10.1089/apc.2005.19.209

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  3 in total

Review 1.  Ophthalmologic Disease in HIV Infection: Recent Changes in Pathophysiology and Treatment.

Authors:  Michael W Stewart
Journal:  Curr Infect Dis Rep       Date:  2017-10-19       Impact factor: 3.725

2.  Presentation of Ocular Syphilis in a HIV-Positive Patient with False-Negative Serologic Screening.

Authors:  Mahsaw N Motlagh; Cameron G Javid
Journal:  Case Rep Infect Dis       Date:  2019-02-03

3.  The importance of proper and prompt treatment of ocular syphilis: a lesson from permanent vision loss in 52 eyes.

Authors:  X Gu; Y Gao; Y Yan; M Marks; L Zhu; H Lu; Z Guan; M Shi; L Ni; R Peng; W Zhao; J Wu; T Qi; S Lu; Y Qian; W Gong; P Zhou
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-25       Impact factor: 6.166

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.